Rothfuss Cristin sold SRPT
March 11, 2026 · Form 4 insider transaction
Rothfuss Cristin sold 974 shares of Sarepta Therapeutics, Inc. at $17.03 per share, a transaction worth $16.6K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
974
Price
$17.03
Total value
$16.6K
InsiderRothfuss Cristin
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 11, 2026
Filing dateMarch 13, 2026
Shares owned after137,544
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025.